Skip to content

Studies on the inhibitory effect of DHA/EPA supplementation on immediate-type food allergic reactions

Studies on the inhibitory effect of DHA/EPA supplementation on immediate-type food allergic reactions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031190192
Enrollment
11
Registered
2020-01-21
Start date
2020-04-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

food allergy

Interventions

Continue to take dairy lactic acid bacteria beverage containing 720mg DHA and 180mg EPA once a day for 5 days or more a week.

Sponsors

Ito Komei
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who tested positive for OFC in eggs (Boiled egg whites) and were instructed to completely remove them. 2) Patients aged between 3 and younger than 10 3) Patients who tasted a test food and are expected to consume it continuously for three months 4) Patients who can receive the test food once a week 5) Patients who are not allergic to milk

Exclusion criteria

Exclusion criteria: 1) Patients who are taking supplements such as DHA containing food or probiotic food continuously. 2) Patients with TS score of 41 or higher induced by initial OFC (Patients for whom the safety of the evaluation OFC is not guaranteed) 3) Patients who have systemic diseases other than allergies 4) Patients who are judged by a physician to be unsuitable

Design outcomes

Primary

MeasureTime frame
Change in ratio of Total score of Anaphylaxis scoring aichi (ASCA) divided by cumulative load protein.

Secondary

MeasureTime frame
Change in plasma total lipid fatty acid fraction: Change in (EPA + DHA) / AA ratio Change in total IgE value Changes in specific IgE levels Changes in intestinal flora analysis

Contacts

Public ContactShiro Sugiura

Aichi Children's Health and Medical Center

allergy-secretary@cd5.so-net.ne.jp+81-562-43-0500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026